vs

Side-by-side financial comparison of Astera Labs, Inc. (ALAB) and Claritev Corp (CTEV). Click either name above to swap in a different company.

Astera Labs, Inc. is the larger business by last-quarter revenue ($270.6M vs $246.6M, roughly 1.1× Claritev Corp). Astera Labs, Inc. runs the higher net margin — 16.6% vs -32.7%, a 49.3% gap on every dollar of revenue. On growth, Astera Labs, Inc. posted the faster year-over-year revenue change (91.8% vs 6.2%). Astera Labs, Inc. produced more free cash flow last quarter ($76.6M vs $36.4M). Over the past eight quarters, Astera Labs, Inc.'s revenue compounded faster (103.6% CAGR vs 2.5%).

Astera Labs, Inc. is an American fabless semiconductor manufacturer and artificial intelligence company. The company specializes in designing high-speed connectivity solutions for data centers and AI infrastructure. The company has been listed on the Nasdaq since March 2024.

ALAB vs CTEV — Head-to-Head

Bigger by revenue
ALAB
ALAB
1.1× larger
ALAB
$270.6M
$246.6M
CTEV
Growing faster (revenue YoY)
ALAB
ALAB
+85.6% gap
ALAB
91.8%
6.2%
CTEV
Higher net margin
ALAB
ALAB
49.3% more per $
ALAB
16.6%
-32.7%
CTEV
More free cash flow
ALAB
ALAB
$40.2M more FCF
ALAB
$76.6M
$36.4M
CTEV
Faster 2-yr revenue CAGR
ALAB
ALAB
Annualised
ALAB
103.6%
2.5%
CTEV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ALAB
ALAB
CTEV
CTEV
Revenue
$270.6M
$246.6M
Net Profit
$45.0M
$-80.6M
Gross Margin
75.6%
Operating Margin
24.7%
-3.1%
Net Margin
16.6%
-32.7%
Revenue YoY
91.8%
6.2%
Net Profit YoY
82.0%
41.6%
EPS (diluted)
$0.25
$-4.88

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALAB
ALAB
CTEV
CTEV
Q4 25
$270.6M
$246.6M
Q3 25
$230.6M
$246.0M
Q2 25
$191.9M
$241.6M
Q1 25
$159.4M
$231.3M
Q4 24
$141.1M
$232.1M
Q3 24
$113.1M
$230.5M
Q2 24
$76.8M
$233.5M
Q1 24
$65.3M
$234.5M
Net Profit
ALAB
ALAB
CTEV
CTEV
Q4 25
$45.0M
$-80.6M
Q3 25
$91.1M
$-69.8M
Q2 25
$51.2M
$-62.6M
Q1 25
$31.8M
$-71.3M
Q4 24
$24.7M
$-138.0M
Q3 24
$-7.6M
$-391.4M
Q2 24
$-7.5M
$-576.7M
Q1 24
$-93.0M
$-539.7M
Gross Margin
ALAB
ALAB
CTEV
CTEV
Q4 25
75.6%
Q3 25
76.2%
Q2 25
75.8%
Q1 25
74.9%
Q4 24
74.0%
Q3 24
77.7%
Q2 24
77.9%
Q1 24
77.4%
Operating Margin
ALAB
ALAB
CTEV
CTEV
Q4 25
24.7%
-3.1%
Q3 25
24.0%
4.1%
Q2 25
20.7%
6.9%
Q1 25
7.1%
4.2%
Q4 24
0.1%
-17.8%
Q3 24
-7.9%
-146.7%
Q2 24
-31.7%
-224.4%
Q1 24
-127.1%
-207.4%
Net Margin
ALAB
ALAB
CTEV
CTEV
Q4 25
16.6%
-32.7%
Q3 25
39.5%
-28.4%
Q2 25
26.7%
-25.9%
Q1 25
20.0%
-30.8%
Q4 24
17.5%
-59.4%
Q3 24
-6.7%
-169.8%
Q2 24
-9.8%
-247.0%
Q1 24
-142.5%
-230.1%
EPS (diluted)
ALAB
ALAB
CTEV
CTEV
Q4 25
$0.25
$-4.88
Q3 25
$0.50
$-4.23
Q2 25
$0.29
$-3.81
Q1 25
$0.18
$-4.38
Q4 24
$1.23
$-8.49
Q3 24
$-0.05
$-24.25
Q2 24
$-0.05
$-35.78
Q1 24
$-1.77
$-33.40

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALAB
ALAB
CTEV
CTEV
Cash + ST InvestmentsLiquidity on hand
$167.6M
$16.8M
Total DebtLower is stronger
$4.6B
Stockholders' EquityBook value
$1.4B
$-173.9M
Total Assets
$1.5B
$4.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALAB
ALAB
CTEV
CTEV
Q4 25
$167.6M
$16.8M
Q3 25
$140.4M
$39.2M
Q2 25
$162.3M
$56.4M
Q1 25
$86.4M
$23.1M
Q4 24
$79.6M
$16.8M
Q3 24
$126.1M
$86.6M
Q2 24
$421.1M
$48.8M
Q1 24
$696.1M
$58.7M
Total Debt
ALAB
ALAB
CTEV
CTEV
Q4 25
$4.6B
Q3 25
$4.5B
Q2 25
$4.5B
Q1 25
$4.5B
Q4 24
$4.5B
Q3 24
$4.5B
Q2 24
$4.5B
Q1 24
$4.5B
Stockholders' Equity
ALAB
ALAB
CTEV
CTEV
Q4 25
$1.4B
$-173.9M
Q3 25
$1.3B
$-101.8M
Q2 25
$1.1B
$-39.9M
Q1 25
$1.0B
$14.8M
Q4 24
$964.8M
$84.0M
Q3 24
$889.6M
$207.6M
Q2 24
$845.3M
$603.4M
Q1 24
$808.8M
$1.2B
Total Assets
ALAB
ALAB
CTEV
CTEV
Q4 25
$1.5B
$4.9B
Q3 25
$1.4B
$5.0B
Q2 25
$1.3B
$5.1B
Q1 25
$1.1B
$5.1B
Q4 24
$1.1B
$5.2B
Q3 24
$983.1M
$5.3B
Q2 24
$915.5M
$5.7B
Q1 24
$864.9M
$6.4B
Debt / Equity
ALAB
ALAB
CTEV
CTEV
Q4 25
Q3 25
Q2 25
Q1 25
304.87×
Q4 24
53.67×
Q3 24
21.73×
Q2 24
7.48×
Q1 24
3.85×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALAB
ALAB
CTEV
CTEV
Operating Cash FlowLast quarter
$95.3M
$66.3M
Free Cash FlowOCF − Capex
$76.6M
$36.4M
FCF MarginFCF / Revenue
28.3%
14.8%
Capex IntensityCapex / Revenue
6.9%
12.1%
Cash ConversionOCF / Net Profit
2.12×
TTM Free Cash FlowTrailing 4 quarters
$281.8M
$-12.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALAB
ALAB
CTEV
CTEV
Q4 25
$95.3M
$66.3M
Q3 25
$78.2M
$19.9M
Q2 25
$135.4M
$61.2M
Q1 25
$10.5M
$-30.1M
Q4 24
$39.7M
$-33.4M
Q3 24
$63.5M
$72.8M
Q2 24
$29.8M
$18.5M
Q1 24
$3.7M
$49.7M
Free Cash Flow
ALAB
ALAB
CTEV
CTEV
Q4 25
$76.6M
$36.4M
Q3 25
$65.9M
$-16.3M
Q2 25
$133.3M
$36.6M
Q1 25
$6.0M
$-68.9M
Q4 24
$24.3M
$-63.8M
Q3 24
$46.8M
$41.1M
Q2 24
$28.5M
$-7.0M
Q1 24
$228.0K
$19.2M
FCF Margin
ALAB
ALAB
CTEV
CTEV
Q4 25
28.3%
14.8%
Q3 25
28.6%
-6.6%
Q2 25
69.5%
15.2%
Q1 25
3.7%
-29.8%
Q4 24
17.2%
-27.5%
Q3 24
41.4%
17.8%
Q2 24
37.1%
-3.0%
Q1 24
0.3%
8.2%
Capex Intensity
ALAB
ALAB
CTEV
CTEV
Q4 25
6.9%
12.1%
Q3 25
5.3%
14.7%
Q2 25
1.1%
10.2%
Q1 25
2.8%
16.8%
Q4 24
10.9%
13.1%
Q3 24
14.8%
13.8%
Q2 24
1.7%
10.9%
Q1 24
5.2%
13.0%
Cash Conversion
ALAB
ALAB
CTEV
CTEV
Q4 25
2.12×
Q3 25
0.86×
Q2 25
2.64×
Q1 25
0.33×
Q4 24
1.61×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons